PRS14 RISK-BENEFIT ASSESSMENT OF TELITHROMYCIN FOR THE TREATMENT OF CAP USING QUALITY-ADJUSTED DAYS (QAD) LOST
May 1, 2005, 00:00
10.1016/S1098-3015(10)62863-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)62863-X/fulltext
Title :
PRS14 RISK-BENEFIT ASSESSMENT OF TELITHROMYCIN FOR THE TREATMENT OF CAP USING QUALITY-ADJUSTED DAYS (QAD) LOST
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62863-X&doi=10.1016/S1098-3015(10)62863-X
First page :
Section Title :
Open access? :
No
Section Order :
300